HLIT:NASDAQHarmonic Inc. Analysis
Data as of 2026-06-21 - not real-time
$15.08
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Harmonic Inc. (HLIT) is trading at $15.08, comfortably above its 20‑day ($14.91), 50‑day ($12.77) and 200‑day ($10.68) SMAs, indicating a strong bullish trend despite a bearish MACD histogram. The RSI of 57.9 suggests the stock is not yet overbought, while the 30‑day volatility of roughly 89% and a beta of 1.73 signal pronounced price swings and heightened market sensitivity. Revenue growth of 43% YoY and a gross margin near 48% underline solid top‑line momentum, yet the company reports a negative profit margin of -10.5% and a sizable free‑cash‑flow deficit, highlighting ongoing profitability challenges. Valuation metrics are mixed: the trailing PE of 188.5 vastly exceeds the industry average of 38, but the forward PE of 19.4 and a DCF‑derived fair value of $12.82 suggest the current price offers only a modest upside of about 1.3%.
Recent deployments of AI‑enhanced XOS processors by Canal Alpha and SeaStar optical nodes by DNA Finland demonstrate tangible demand for Harmonic’s cloud‑native broadband solutions, supporting the bullish narrative seen in analyst consensus (Buy) and a median target price of $15.00. The surge in earnings estimates and strong YTD performance (+71.9%) have propelled the stock to a 52‑week high of $17.68, reflecting heightened investor optimism amid “Extreme Greed” market sentiment. However, decreasing volume trends and a recent bearish MACD signal advise caution, as the stock may encounter resistance near $17.68 before confirming a sustained breakout.
Recent deployments of AI‑enhanced XOS processors by Canal Alpha and SeaStar optical nodes by DNA Finland demonstrate tangible demand for Harmonic’s cloud‑native broadband solutions, supporting the bullish narrative seen in analyst consensus (Buy) and a median target price of $15.00. The surge in earnings estimates and strong YTD performance (+71.9%) have propelled the stock to a 52‑week high of $17.68, reflecting heightened investor optimism amid “Extreme Greed” market sentiment. However, decreasing volume trends and a recent bearish MACD signal advise caution, as the stock may encounter resistance near $17.68 before confirming a sustained breakout.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above key SMAs indicating bullish momentum
- Recent strong earnings estimate revisions
- Technical support at $12.18 and upward price trajectory
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward PE of 19.4 suggests reasonable valuation
- Pending execution of AI‑driven product deployments
- Potential volatility around resistance near $17.68
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High revenue growth and expanding software recurring revenue
- Current profitability and cash‑flow deficits
- Exposure to technology sector cycles and high beta
Key Metrics & Analysis
Financial Health
Revenue Growth43.40%
Profit Margin-10.56%
P/E Ratio188.5
ROE2.12%
ROA2.57%
Debt/Equity36.90
P/B Ratio4.6
Op. Cash Flow$56.1M
Free Cash Flow$-81867248
Industry P/E38.1
Technical Analysis
TrendBullish
RSI57.9
Support$12.18
Resistance$17.68
MA 20$14.91
MA 50$12.77
MA 200$10.68
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair Value$12.82
Target Price$15.29
Upside/Downside1.36%
GradeFair
TypeGrowth
Risk Assessment
Beta1.73
Volatility89.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.